Bio Path Holdings Inc
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in … Read more
Bio Path Holdings Inc (BPTH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.000x
Based on the latest financial reports, Bio Path Holdings Inc (BPTH) has a cash flow conversion efficiency ratio of 0.000x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($0.00) by net assets ($-8.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio Path Holdings Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Bio Path Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bio Path Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio Path Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Petrochemical
TA:PTCH
|
-0.001x |
|
RAINY MOUNTAIN ROYAL. NEW
F:EK7C
|
N/A |
|
Canada One Mining Corp.
PINK:COMCF
|
0.009x |
|
Citrus Plant5-L
TA:CTPL5
|
-0.004x |
|
AMADEUS IT HOLD -A-
BE:AI3A
|
0.093x |
|
Yuhan Corp. Pfd. Series 1
KQ:000105
|
N/A |
|
ECG-WI
NYSE:ECG-WI
|
N/A |
|
Wisconsin Electric Power Company PFD 3.60%
OTCQB:WELPP
|
0.048x |
Annual Cash Flow Conversion Efficiency for Bio Path Holdings Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Bio Path Holdings Inc from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $154.00K | $-10.57 Million | -68.669x | -162.53% |
| 2023-12-31 | $441.00K | $-11.54 Million | -26.156x | -2354.76% |
| 2022-12-31 | $14.17 Million | $-15.10 Million | -1.066x | -173.53% |
| 2021-12-31 | $25.46 Million | $-9.92 Million | -0.390x | +46.44% |
| 2020-12-31 | $15.07 Million | $-10.96 Million | -0.727x | -83.41% |
| 2019-12-31 | $21.09 Million | $-8.36 Million | -0.397x | +92.11% |
| 2018-12-31 | $1.22 Million | $-6.12 Million | -5.028x | -409.74% |
| 2017-12-31 | $8.07 Million | $-7.96 Million | -0.986x | +0.25% |
| 2016-12-31 | $8.24 Million | $-8.15 Million | -0.989x | -94.00% |
| 2015-12-31 | $9.82 Million | $-5.00 Million | -0.510x | -99.16% |
| 2014-12-31 | $14.92 Million | $-3.82 Million | -0.256x | +47.07% |
| 2013-12-31 | $4.78 Million | $-2.31 Million | -0.484x | +51.14% |
| 2012-12-31 | $2.01 Million | $-1.99 Million | -0.990x | -150.84% |
| 2011-12-31 | $2.91 Million | $-1.15 Million | -0.394x | +1.68% |
| 2010-12-31 | $2.86 Million | $-1.15 Million | -0.401x | +12.54% |
| 2009-12-31 | $3.42 Million | $-1.57 Million | -0.459x | -100.14% |
| 2008-12-31 | $4.06 Million | $-930.60K | -0.229x | -149.59% |
| 2007-12-31 | $-140.43K | $-64.91K | 0.462x | -54.40% |
| 2006-12-31 | $-100.39K | $-101.76K | 1.014x | +226.04% |
| 2005-12-31 | $-176.79K | $-54.96K | 0.311x | 0.00% |
| 2004-12-31 | $-176.79K | $-54.96K | 0.311x | -36.99% |
| 2003-12-31 | $-92.25K | $-45.52K | 0.493x | -- |